等待開盤 11-04 09:30:00 美东时间
0.000
0.00%
Tonix Pharmaceuticals' TONMYA (cyclobenzaprine HCl sublingual tablets) demonstrated statistically significant improvements in Fibromyalgia Impact Questionnaire-Revised (FIQR) symptoms and function scores versus placebo in two Phase 3 studies (RELIEF and RESILIENT). The drug, approved by the FDA in August 2025, is the first new prescription treatment for fibromyalgia in over 15 years. TONMYA was launched commercially in November 2025 and showed im...
10-27 11:00
Residential Secure Income ( ($GB:RESI) ) has issued an update. Residential Secu...
07-03 00:08